AYTU
Aytu BioPharma·NASDAQ
--
--(--)
--
--(--)
7.78 / 10
Outperform
AYTU's financial analysis yields an exceptionally strong rating (7.8/10). Key positives include a robust interest-coverage ratio (EBIT/Interest expense = 42.48) and favorable Revenue-MV (1.31) and Profit-MV (0.44) differences, which rank in high-performing groups. However, challenges persist in Total Operating Revenue YoY growth (1.84%) and Days Sales Outstanding (148.27), which lag behind peers. These factors collectively point to a fundamentally sound micro-cap with room for operational improvement.
Analysis Checks(7/10)
Revenue-MV
Value1.31
Score3/3
Weight18.00%
1M Return10.54%
Value1.31
Score3/3
Weight18.00%
1M Return10.54%
Days sales outstanding
Value148.27
Score0/3
Weight-6.36%
1M Return-5.18%
Value148.27
Score0/3
Weight-6.36%
1M Return-5.18%
Net income-Revenue
Value0.15
Score2/3
Weight14.37%
1M Return8.45%
Value0.15
Score2/3
Weight14.37%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.44%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.44%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight26.61%
1M Return13.15%
Value-0.50
Score3/3
Weight26.61%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value1.84
Score1/3
Weight-1.05%
1M Return-0.79%
Value1.84
Score1/3
Weight-1.05%
1M Return-0.79%
Profit-MV
Value0.44
Score3/3
Weight17.30%
1M Return9.28%
Value0.44
Score3/3
Weight17.30%
1M Return9.28%
PB-ROE
Value-0.92
Score3/3
Weight19.46%
1M Return12.83%
Value-0.92
Score3/3
Weight19.46%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value1.84
Score1/3
Weight-1.01%
1M Return-0.76%
Value1.84
Score1/3
Weight-1.01%
1M Return-0.76%
Cash-MV
Value1.01
Score2/3
Weight14.11%
1M Return8.41%
Value1.01
Score2/3
Weight14.11%
1M Return8.41%
Revenue-MV
Value1.31
Score3/3
Weight18.00%
1M Return10.54%
Value1.31
Score3/3
Weight18.00%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value1.84
Score1/3
Weight-1.05%
1M Return-0.79%
Value1.84
Score1/3
Weight-1.05%
1M Return-0.79%
Days sales outstanding
Value148.27
Score0/3
Weight-6.36%
1M Return-5.18%
Value148.27
Score0/3
Weight-6.36%
1M Return-5.18%
Profit-MV
Value0.44
Score3/3
Weight17.30%
1M Return9.28%
Value0.44
Score3/3
Weight17.30%
1M Return9.28%
Net income-Revenue
Value0.15
Score2/3
Weight14.37%
1M Return8.45%
Value0.15
Score2/3
Weight14.37%
1M Return8.45%
PB-ROE
Value-0.92
Score3/3
Weight19.46%
1M Return12.83%
Value-0.92
Score3/3
Weight19.46%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.44%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.44%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value1.84
Score1/3
Weight-1.01%
1M Return-0.76%
Value1.84
Score1/3
Weight-1.01%
1M Return-0.76%
Asset-MV
Value-0.50
Score3/3
Weight26.61%
1M Return13.15%
Value-0.50
Score3/3
Weight26.61%
1M Return13.15%
Cash-MV
Value1.01
Score2/3
Weight14.11%
1M Return8.41%
Value1.01
Score2/3
Weight14.11%
1M Return8.41%
Is AYTU undervalued or overvalued?
- AYTU scores 7.78/10 on fundamentals and holds a Discounted valuation at present. Backed by its -51.97% ROE, -39.02% net margin, -1.05 P/E ratio, 1.81 P/B ratio, and -252.58% earnings growth, these metrics solidify its Outperform investment rating.
